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Mavroudis et al Surgery for Congenital Heart Disease
Objectives: Hemodynamic abnormalities and refractory atrial arrhythmias in
patients late after the Fontan operation result in significant morbidity and mortality.
We review our experience with conversion to total cavopulmonary artery connec-
tions and arrhythmia surgery.
Methods: Between 1994 and 2001, 40 patients underwent Fontan conversion and
arrhythmia surgery. Significant hemodynamic lesions such as aortic aneurysm (n =
1), atrioventricular valve insufficiency (n = 8), and pulmonary arterioplasty (n = 9)
were repaired concomitantly. Thirty-four patients were in New York Heart
Association class III or IV. Mean age at the original Fontan operation was 7.5 ± 6.5
years and mean age at Fontan conversion was 18.7 ± 9.0 years. Arrhythmia surgery
has evolved from isthmus cryoablation in 10 patients to right-sided maze in 16
patients for atrial reentry tachycardia. The maze–Cox III operation was used for 14
patients with atrial fibrillation. Atrial (n = 33) and dual-chamber (n = 5) pacemak-
ers were placed.
Results: There has been no early mortality. Chest tubes were removed on postoper-
ative day 9.0 ± 6.0. Hospital stay was 11.8 ± 6.6 days. Three patients required car-
diac transplantation at 8 days, 9 months, and 33 months postoperatively. There was
1 death 2 years postoperatively from acute myocardial infarction. For the entire
series, arrhythmia recurrence is 12.5%, with only 10% of patients receiving long-
term antiarrhythmic medications; these patients were among the first 8 patients in
our series. Most patients are in New York Heart Association class I or II. Bruce pro-
tocol in 12 patients showed increased tolerance (P < .05). 
Conclusions: Fontan conversion to total cavopulmonary connection with concomi-
tant arrhythmia surgery is excellent therapy for patients whose Fontan repair has
failed. Fontan conversion is safe, improves New York Heart Association class,
improves exercise tolerance, and has a low incidence of recurrent arrhythmias. 
Complications after the Fontan operation are related to follow-upduration and include atrial arrhythmias, circulatory pathwayobstructions, decreased ventricular function, increasing cyanosis,and protein-losing enteropathy, among others.1-4 Most of thesecomplications occur in patients with atriopulmonary connections asopposed to the newer reconstructions in which total cavopulmonary
artery connections (TCPC) with lateral tunnel or extracardiac techniques are used.5-9
Whether this difference is due to the longer follow-up time of patients with atri-
opulmonary connections or the demonstrated improved flow characteristics of
Drs Mavroudis, Deal, and Backer (left to right)
864 The Journal of Thoracic and Cardiovascular Surgery • November 2001
ED
ITO
RIA
L
CH
D
G
TS
A
CD
ET
CSP
TX
TCPC10,11 and decreased suture load12 remains to be
reviewed as the TCPC group accrues longer follow-up time.
Whatever the eventual outcome of the TCPC Fontan pro-
cedure, the extant group of patients who had the atriopul-
monary Fontan operation is presenting with an increasing
incidence of complications that are often amenable to recon-
structive and arrhythmia ablative techniques. Our previous
reports on this subject introduced the idea that atriopulmonary
Fontan conversion to TCPC in association with arrhythmia
ablative surgery could be safely performed with a high degree
of efficacy and improved functional class.13-15 These results
were in contrast with previous16-19 and subsequent20,21 reports
in which Fontan conversion was performed without arrhyth-
mia surgery, resulting in excellent hemodynamic results but a
collective 76% postoperative arrhythmia recurrence. Since our
previous report,13 our arrhythmia ablative techniques have
evolved into standard right-sided and left-sided procedures to
treat atrial reentry tachycardia and atrial fibrillation, respec-
tively. The purpose of this article is to document the matured
right- and left-sided arrhythmia ablative procedures and
update the clinical results of our enlarged series of patients.
Surgery for Congenital Heart Disease Mavroudis et al
Patients and Methods 
Patient Population 
Between 1994 and 2001, 40 patients underwent Fontan conversion
and arrhythmia surgery. The clinical characteristics of our patient
population are noted in Table 1. Hemodynamic abnormalities were
present in 38 of 40 patients; the New York Heart Association classifi-
cation was class II in 4 patients, class II-III in 2 patients, class III in
28 patients, class III-IV in 1 patient, and class IV in 5 patients. Thirty
patients had a severely dilated right atrium; 8 had elevated ventricu-
lar end-diastolic pressure (≥12 mm Hg); 8 had a right atrium–
pulmonary artery gradient greater than 2 mm Hg; 5 had pulmonary
vein obstruction; 7 had right-to-left shunting; and 1 had significant
pulmonary arteriovenous fistulas resulting from preexisting right
Glenn–right atrial–left pulmonary connections. No patient in this
series had significant protein-losing enteropathy. In 12 of 16 patients
completing a standard Bruce treadmill protocol, both preoperative
and postoperative evaluation were completed and results were com-
pared by the Student t test. 
During this time period, 11 patients were evaluated for cardiac
transplantation. Six of these underwent Fontan conversion because
the ventricular dysfunction could be ascribed to arrhythmogenic or
anatomic substrates, with a chance that the ventricular function
would improve if these problems could be successfully addressed.
TABLE 1. Patient characteristics
Isthmus block (n = 10) Modified maze (n = 16) Maze–Cox III (n = 14) P value
Diagnosis, n (%) TA 6 (60%) 4 (25%) 11 (78%)
DILV 1 (10%) 4 (25%) 1 (7%)
SV 3 (30%) 2 (12.5%) 0
DORV, mitral atresia 0 2 (12.5%) 2 (14%)
HLHS 0 2 (12.5%) 0
Hypoplastic RV, PS 0 2 (12.5%) 0
Age at first Fontan (y) 6.1 ± 3.0 6.1±3.9 9.9 ± 9.4 NS
Age at SVT onset (y) 11.7 ± 5.7 11.0 ± 7.2 15.1 ± 8.4 NS
Catheterization results RAp (mm Hg) 16.2 ± 3.2 14.9 ± 2.2 14.3 ± 2.9 NS
RVEDP or LVEDP (mm Hg) 8.0 ± 3.7 7.6 ± 2.0 8.7 ± 3.2 NS
CI (L · min-1 · m2) 2.3 ± 0.7 2.9 ± 0.7 2.3 ± 0.6 NS
Age at CMH Fontan 15.6 ± 5.1 16.2 ± 7.7 23.3 ± 10.5 P = .01
conversion (y)
Interval: SVT onset to 3.6 ± 2.4 5.9 ± 3.8 8.3 ± 4.1 P = .02
CMH Fontan conversion
Intraoperative results CPB time (min) 256 ± 91.6 205.2 ± 86.2 271 ± 68.8 NS
Crossclamp time (min) 21.4 ± 32.1 66.1 ± 57.2 97.5 ± 25.6 P = .003
Associated repairs PA plasty 4 2 3
Valve repair 0 5 1
Valve replacement 0 1 1
Aortic root replacement 0 0 1
Postoperative complications Renal failure (creatinine > 2.0) 0.8 ± 0.2 0.8 ± 0.2 2.1 ± 1.8 P = .001
CI, Cardiac index; CMH, Children’s Memorial Hospital; CPB, cardiopulmonary bypass; DILV, double-inlet left ventricle; DORV, double-outlet right ventricle;
HLHS, hypoplastic left heart syndrome; LVEDP, left ventricular end-diastolic pressure; NS, not significant; PA, pulmonary artery; PAp, mean pulmonary
artery pressure; PS, pulmonary stenosis, RV, right ventricle; RAp, mean right atrial pressure; RVEDP, right ventricular end-diastolic pressure; SV, single
ventricle; SVT, supraventricular tachycardia; TA, tricuspid atresia. Because isthmus block and the modified right-sided maze procedure are right atrial pro-
cedures, the results were combined and then compared with the more extensive right- and left-sided maze–Cox III procedure by the Student t test. This
comparison emphasizes the significant differences between operations that are performed for atrial reentry tachycardia and atrial fibrillation. 
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Another 5 patients, not included in our original cohort of 40 patients,
had ventricular dysfunction that could not be ascribed to arrhythmo-
genic or anatomic substrates. These patients were listed for cardiac
transplantation without consideration for Fontan conversion. The
clinical outcome of all patients who were considered for cardiac
transplantation is noted in Figure 1. 
Arrhythmia Management 
All patients with atrial reentry tachycardia underwent preoperative,
intraoperative, and postoperative electrophysiologic study and map-
ping, the results of which are published elsewhere.14,15 Early in our
series, isthmus block via cryoablation at the area between the coro-
nary sinus os and the inferior vena cava os and the right-sided atri-
oventricular valve (when present) was performed.13 On the basis of
the multiplicity of reentrant circuits identified at preoperative and
intraoperative electrophysiologic assessment, the cryoablation proce-
dure was extended to three main parts of the right atrium.13 Since that
report, we have standardized intraoperative arrhythmia management
by performing a modified right-sided maze procedure (Figures 2-4)
for patients with atrial reentry tachycardia and a maze–Cox III oper-
ation (Figure 5) for patients with atrial fibrillation.22 Twenty-five
patients had right-sided arrhythmia surgery and were treated for atrial
reentry tachycardia; 8 with isthmus cryoablation and 15 with the stan-
dard modified right-sided maze procedure. Two patients without
prior atrial tachycardia underwent prophylactic cryoablation, 1 with
isthmus ablation and 1 with the modified right-sided maze procedure.
Fifteen patients had arrhythmia surgery for atrial fibrillation, 14 with
the standard maze–Cox III procedure and 1 with isthmus ablation.
Interestingly, all patients who had atrial fibrillation also had a history
of recurrent atrial reentry tachycardia, which underlines the linear
propensity for arrhythmia degeneration.
Thirty-eight of 40 patients had a planned pacemaker implantation
or replacement (n = 3) at the time of Fontan conversion consistent with
our original protocol13 for management of sinus node dysfunction. In
our early experience, we implanted antitachycardia pacemakers in the
event of arrhythmia ablation failure. Because the Intermedics Intertach
II (Intermedics, Inc, Angleton, Tex) antitachycardia pacemaker was
withheld from the market, we converted to atrial rate–responsive pace-
makers (Medtronic, Inc, Minneapolis, Minn; Thera DR). The ratio-
nales for pacemaker implantation are the high incidence of sinus node
dysfunction in these patients, the desirability of rate-responsive paced
sinus rhythm, and the lack of venous access to the heart in these
patients, which would require mandatory thoracotomy for subsequent
pacemaker implantation. Our bias is to maintain a regular paced atrial
rhythm to prevent bradycardia and to decrease atrial extrasystoles,
which are substrates for atrial reentry tachycardia. Seven had an atrial
antitachycardia pacemaker (not currently available), 26 had an atrial
rate–responsive pacemaker, and 5 had a dual-chamber pacemaker.
Perioperative prophylactic arrhythmia management has evolved over
the course of the study. Unless contraindicated by noncardiac prob-
lems, after surgery we administer oral β-blockade for 3 months to
patients who had atrial reentry tachycardia and oral amiodarone for 3
months to those who had atrial fibrillation.
Anatomic Conversion 
The preoperative Fontan reconstructions were mostly atriopulmonary
connections (n = 31), of which 8 had divided circulations consisting
Figure 1. Road map figure noting the outcome of the 11 patients
with failed Fontan operations who were initially considered for
cardiac transplantation. Six patients, who are included in our
cohort of 40 patients, had Fontan conversion with arrhythmia
surgery. Five are alive and well 1.1 ± 0.5 years postoperatively and
1 had a subsequent cardiac transplant and is alive and well 1.8
years after transplantation. Five, not included in our original
cohort of 40 patients, were listed for cardiac transplantation. Two
died on the waiting list and the other 3 had cardiac transplanta-
tion. Only 1 of these patients survives, 1.6 years postoperatively.
The other 2 died 1 and 4.2 years after the transplant operation.
Figure 2. Atrial view of a patient who had an atriopulmonary Fontan
operation after aortic crossclamping and cardioplegic arrest. The
inferior and superior venae cavae have been transected, the atrial
wall excision has been performed, and the atrial septal patch has
been removed. No measures are taken to preserve the sinoatrial
node, which is nonfunctional in a significant number of patients.
Cryoablation lesions (–60°C for 90 seconds) are placed in 3 areas to
complete the modified right-sided maze procedure. The first 2
cryoablation lesions are standard for all anatomic substrates and
are performed by connecting (1) the superior portion of the atrial
septal ridge with the incised area of the right atrial appendage and
(2) the posterior portion of the atrial septal ridge with the posterior
cut edge of the atrial wall, which extends through the crista termi-
nalis. The third part is the isthmus ablation. These lines of block are
dependent on the anatomic substrate. In patients with tricuspid
atresia, as noted here, the cryoablation lesion is placed to connect
(3) the posteroinferior portion of the coronary sinus os with the tran-
sected inferior vena cava os.
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of right Glenn–right atrium–left pulmonary artery anastomoses. Six
patients had Björk modifications (right atrium–small right ventricle
connections); 2 had total cavopulmonary artery lateral tunnel con-
nections; and 1 had an intra-atrial graft reconstruction for hetero-
taxy syndrome. Thirty-eight of 40 patients had TCPC, of whom
32 had extracardiac and 6 had lateral tunnel inferior vena cava–
pulmonary artery connections. In 7 of the 8 patients with a divided
pulmonary circulation, the circulation was reconnected by homo-
graft or polytetrafluoroethylene* tube grafts. A liberal right atrial
wall resection was performed without regard to preservation of the
sinoatrial node, because all patients receive an atrial or dual-cham-
ber pacemaker. Only 1 patient in the entire series had a fenestration,
which was associated with a lateral tunnel reconstruction. In 1 early
patient the right atrial–left pulmonary artery connection was
revised, and in the other patient the Fontan circulation was con-
verted to a one and a half ventricle repair because of the interim
growth of the right ventricle.23 The mean/median ages at the initial
Fontan operation were 7.5 ± 6.5 years and 5.7 years, respectively.
The mean/median ages at the latest Fontan conversion were 18.7 ±
9.0 years and 16.5 years, respectively. Associated surgical proce-
dures were performed as required by the anatomic substrates. The
procedures included atrioventricular valve repair/replacement in 8
patients, pulmonary artery arterioplasty in 9 patients, and aortic root
Surgery for Congenital Heart Disease Mavroudis et al
replacement in 1 patient. Femoral cannulation during or before
median resternotomy was required for excessive bleeding,
unwanted cavitary entry, or dissection enhancement in 5 patients.
Follow-up Monitoring 
All patients received follow-up on at least a yearly basis with physical
examination, echocardiogram, electrocardiogram, continuous 24-hour
electrocardiographic monitoring, and pacemaker analysis. Exercise
testing was obtained in 16 patients postoperatively, with both preoper-
ative and postoperative assessment in 12 of 16. Although these 12
patients had combinations of pathway obstruction and atrial tachycar-
dia, the primary indication for Fontan conversion and arrhythmia
surgery was atrial reentry tachycardia in 7, pathway obstruction in 4,
and circular venous circulation caused by right atrial–main pulmonary
artery connection and TCPC in 1. None of these 12 patients had pre-
existing valve lesions. The average follow-up time was 2.5 ± 1.9 years
(range 1 month–6.3 years) and was complete. All patients were given
warfarin sodium (Coumadin; international normalized ratio, 2-2.5);
none has been converted to antiplatelet therapy.
Statistical Analysis
Means are expressed as ± standard deviation; comparison of groups
with normal distribution was analyzed by the Student t test. Because
isthmus block and the modified right-sided maze procedure are right
atrial procedures, the results were combined and then compared with
the more extensive right- and left-sided maze–Cox III procedure by
the Student t test. This comparison emphasizes the significant differ-
Figure 4. This drawing demonstrates the modified right-sided maze
procedure in a patient with single ventricle and unbalanced atri-
oventricular canal. As noted in Figure 2, the 2 standard cryoablation
lesions connecting the rim of the atrial septal defect with (1) the
incised area of the right atrial appendage and (2) the posterior cut
edge of the atrial wall, respectively, are shown. The isthmus block is
accomplished by creating cryoablation lesions (3) to connect the
posteroinferior portion of the coronary sinus os with the transected
inferior vena cava os and (4) to connect the common atrioventricular
valve anulus with the transected inferior vena cava os. These isth-
mus block lesions are usually placed across the ridge of the
resected atrial compartmentalization patch.
Figure 3. This drawing demonstrates the modified right-sided
maze procedure in a patient with double-outlet right ventricle and
mitral atresia. As noted in Figure 2, the 2 standard cryoablation
lesions connecting the rim of the atrial septal defect with (1) the
incised area of the right atrial appendage and (2) the posterior cut
edge of the atrial wall, respectively, are shown. The isthmus block
is accomplished by creating cryoablation lesions (3) to connect
the posteroinferior portion of the coronary sinus os with the tran-
sected inferior vena cava os, and (4) to connect the tricuspid valve
anulus with the transected inferior vena cava os. These isthmus
block lesions are usually placed across the ridge of the resected
atrial compartmentalization patch.
*Gore-Tex graft; registered trade name of W. L. Gore & Associates, Inc,
Flagstaff, Ariz.
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ences between operations that are performed for atrial reentry tachy-
cardia and atrial fibrillation. 
Results
Operative Outcomes 
All patients survived the operation (0% mortality). No patient
required reexploration for bleeding. The average hospital stay
was 11.8 ± 6.8 days (range 7-36 days, median 10 days). Chest
tube output was favorable in most cases (removal of the last chest
tube on postoperative day 9.0 ± 6.0 days, range 5-36 days,
median 7.5 days). 
Complications 
One 47-year-old man with tricuspid atresia had his initial
Fontan operation at 35 years of age and presented with an ele-
vated left ventricular end-diastolic pressure (13 mm Hg) and
atrial fibrillation. Acute renal failure developed postopera-
tively, resulting in fluid retention, recurrence of atrial fibrilla-
tion, and cardiac decompensation 7 days postoperatively. He
was supported with a ventricular assist device and required
expeditious cardiac transplantation 16 hours later. He is doing
well 17 months postoperatively and is awaiting renal trans-
plantation. One 40-year-old woman with an associated
ascending aortic aneurysm repair had a deep mediastinal
infection, which was successfully treated by debridement and
myocutaneous flaps at another institution without long-term
sequelae. Five patients in the maze–Cox III group had acute
renal failure manifested by oliguria and a perioperative rise in
the serum creatinine measurement (peak postoperative creati-
nine level 4.8 ± 1.1 mg/dL), presumably because of suscepti-
bility to renal insufficiency from long-standing heart failure,
prolonged cardiopulmonary bypass time, excessive car-
diotomy suction, and resultant hemoglobinuria. All responded
to conservative measures except the cardiac transplant patient,
as noted above. Oxygen saturations improved postoperatively
from 72% to 93% within 4 months and to 98% at 14 months’
follow-up in the 1 patient who had significant pulmonary arte-
riovenous fistulas. 
Arrhythmia Status 
Two patients had transient perioperative heart block, which
resolved. Overall recurrence of tachycardia is 5 of 40 patients
(12.5%) with a mean follow-up of 30.0 ± 22.6 months.
Among 23 patients with atrial reentry tachycardia, isthmus
cryoablation was performed in 8 and a modified right atrial
maze procedure in 15 patients. Atrial tachycardia recurred
late postoperatively in 4 of 8 patients undergoing isthmus
cryoablation and in none of those undergoing a modified right
atrial maze procedure (P < .05). β-Blocking medications
were effective in 3 patients, and 1 patient is receiving no med-
ications, treated with the antitachycardia pacemaker with 66
months’ follow-up. Among 15 patients with atrial fibrillation,
isthmus cryoablation was performed in 1 patient, who is
receiving amiodarone therapy for chronic atrial fibrillation 51
months postoperatively. Of 14 patients undergoing the
maze–Cox III procedure for atrial fibrillation, 4 (29%) had
acute perioperative supraventricular tachycardia, and 1
patient underwent heart transplantation. During long-term
follow-up of 19 ± 18 months, with discontinuation of antiar-
rhythmic medications 3 months postoperatively, none of 13
patients have had recurrence of supraventricular tachycardia.
Figure 5. Left atrial view of a univentricular heart that shows the
standard incisions, excisions, and cryoablation lesions which,
when combined with the right atrial component (see Figures 2-4),
complete the maze–Cox III procedure. The incisions include a
partial encircling pulmonary vein isolation and a left atrial
appendage resection. Standard cryoablation lesions (–60°C for 90
seconds) are placed to complete the pulmonary vein isolation, to
create a cryoablation lesion from the isolated pulmonary veins
toward the posterior mitral or tricuspid valve anulus, and to
extend the pulmonary vein isolation to the cut edge of left atrial
appendage base. A large cryoablation probe (15 mm) is used to
place a lesion on the coronary sinus (–60°C for 180 seconds).
(Copyright © 2001 R. F. Idriss.)
Figure 6. Bar graph showing the results of exercise tolerance
(Bruce protocol) before and after Fontan conversion and arrhyth-
mia surgery (P < .05; Student t test).
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Two patients underwent prophylactic arrhythmia surgery:
isthmus cryoablation in 1 and modified right atrial maze pro-
cedure in the other. Neither patient has had tachycardia dur-
ing 40 months’ follow-up.
Late Follow-up 
There was 1 late death (3%) 2 years postoperatively in a 26-
year-old man who had an acute myocardial infarction as a
result of right coronary artery occlusive thrombosis and was
found to have diffuse obstructive atherosclerotic coronary
artery disease at autopsy. He had no positive family history,
and his lipid profile was unknown. Two other patients with
double-outlet right ventricle required cardiac transplanta-
tion 2.8 years and 9 months postoperatively because of
decreasing ventricular function in both. No clinical throm-
boembolic or hemorrhagic events have been noted.
Exercise Endurance 
Sixteen patients have undergone follow-up Bruce exercise
tolerance testing at this institution from 1 to 4 years postop-
eratively. In 12 patients both preoperative and postoperative
evaluations were performed. The results of the most recent
evaluations demonstrate that exercise endurance improved
significantly from 6.51 ± 1.20 minutes to 8.40 ± 1.51 min-
utes (P < .05, paired Student t test). There was a significant
improvement in New York Heart Association class (P <
.001, Mann-Whitney rank sum test): class I, 12 patients;
class I-II, 17 patients; class II, 5 patients; class III, 3
patients; and class IV, 3 patients (all patients with class IV
cardiac function eventually required cardiac transplanta-
tion). This was corroborated by an increase in exercise tol-
erance (Bruce protocol) after Fontan conversion and
arrhythmia surgery (Figure 6). 
Discussion
Our findings demonstrate that atriopulmonary to total
cavopulmonary Fontan conversion in association with arrhyth-
mia surgery is a highly effective and safe operation, which
results in near-uniform arrhythmia control, increased func-
tional class, and increased exercise tolerance. Our selection
criteria were liberal and included patients with severe ventric-
ular dysfunction, cyanosis-causing pulmonary arteriovenous
fistulas, and significant associated cardiac lesions. However,
no patient had debilitating protein-losing enteropathy, which is
a known risk factor for poor outcome.4 Eleven patients were
evaluated for cardiac transplantation because of severe ven-
tricular dysfunction (Figure 1). Six of those who eventually
underwent Fontan conversion and arrhythmia surgery had
anatomic and arrhythmogenic substrates amenable to surgery.
The other 5 (not included in our original cohort of 40 patients)
had severe ventricular dysfunction, which could not be
ascribed to atrial arrhythmias or anatomic lesions; 3 of these
patients had cardiac transplantation and the other 2 died while
Surgery for Congenital Heart Disease Mavroudis et al
on the waiting list. Cardiac transplantation after Fontan con-
version was performed in 3 of our patients from the original
cohort, which is similar to the incidence reported in long-term
follow-up studies.24
Arrhythmia Surgery 
The operation that we first introduced in 1994 for patients with
anatomic hemodynamic problems and debilitating arrhythmias
after the Fontan operation has undergone a significant meta-
morphosis13,14,22 based on the analysis of our extensive electro-
physiologic findings.15 We found an unacceptable arrhythmia
recurrence after Fontan conversion with isthmus block alone
(4/8 patients). Using extensive electrophysiologic mapping, we
identified additional areas of atrial reentry for which simple
isthmus block was not adequate. We have identified 3 common
sites within the right atrium important to these reentrant cir-
cuits: (1) the area between the coronary sinus os and the infe-
rior vena cava os/right-sided atrioventricular anulus, (2) the
region of the atrial septal defect patch, and (3) the lateral right
atrial wall. These areas of reentry became the target for our
revised approach to atrial reentry tachycardia, which resulted in
the modified right-sided maze procedure.22 We use the term
“modified” to distinguish this arrhythmia operation from the
“right-sided maze procedure” that was used by Theodoro and
associates25 in patients with congenital heart disease not
amenable to the Fontan procedure.
Anatomic Variants 
We found that the anatomic substrate had a profound effect
on how we handled the cryoablation lesion at the isthmus
(area between the coronary sinus os, when present, and the
right-sided atrioventricular valve, when present). In patients
with tricuspid atresia, the cryoablation lesion is placed from
the coronary sinus os to the inferior vena cava os. The
absence of a tricuspid anulus and the close proximity to the
underlying atrioventricular node and coronary artery miti-
gate against placement of additional lesions in this area.26,27
The issue of isthmus block becomes more difficult when
considering other single ventricle diagnoses. In general,
cryoablation lesions can be placed to connect the coronary
sinus os with the associated atrioventricular valve to achieve
isthmus block and avoid complete heart block. Patients with
single ventricle who have a defined right atrium, coronary
sinus, and right ventricle have the same predictive location
of the atrioventricular node in the triangle of Koch as do
patients with normal anatomy.28 The relationship of the
coronary sinus to the atrioventricular node in patients with
double-inlet left ventricle, unbalanced atrioventricular
canal, and other complex forms of single ventricle are less
predictive and cannot be relied on to identify the atrioven-
tricular node,29 nor can the distance between the coronary
sinus and the anulus in these patients be interpreted as the
isthmus, even though in our practice we have treated it as
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such. Oftentimes the distance between the coronary sinus
and the atrioventricular valve is long and quite distinct from
the normal anatomy on which extensive studies are based.30
More detailed electrophysiologic mapping in these complex
forms of single ventricle will be necessary to determine
whether the area between the coronary sinus os and the atri-
oventricular valve participates in atrial reentry tachycardia.
Arrhythmia Recurrence 
For the entire series, arrhythmia recurrence is 12.5%, with
only 10% of patients receiving long-term antiarrhythmic
medications; these patients were among the first 8 patients in
our series. Since applying the more extensive modified right-
sided maze procedure for atrial reentry tachycardia, we have
had no recurrence of atrial tachycardia in subsequent
patients. Similarly, isthmus cryoablation was ineffective for
atrial fibrillation, which has been eliminated with the use of
the maze–Cox III procedure. The maze–Cox III procedure
represents a combination of the right-sided maze procedure,
appropriate for anatomic substrate (Figures 2-4), combined
with the left-sided series of incisions and cryoablation
lesions as described by Cox and associates31 (Figure 5).
Some authors32,33 have used intraoperative radiofrequency
ablation and microwave energy, which are associated with
higher recurrence rates. Others report that a right-sided pro-
cedure will effectively treat patients who have congenital
heart disease with accompanying atrial fibrillation20,25; long-
term data are not available in that population. Similar to our
experience, other studies show recurrence of atrial fibrilla-
tion with lesions limited to the right atrium.24,34 Recurrent
atrial fibrillation in our single ventricle population causes
unfavorable hemodynamic consequences, which are less
well tolerated than in the two ventricle population. Because
of this, we prefer to perform the maze-Cox procedure, which
is associated with the lowest recurrence rate.
Relative Morbidity 
Most of the morbidity in our series occurred in the atrial fib-
rillation group, which had the maze–Cox III procedure.
These patients were older at Fontan conversion (P < .01),
had atrial arrhythmias for a longer time (P < .02), had a
longer aortic crossclamp time (P < .003), and had a higher
incidence of perioperative renal insufficiency (P < .0001)
than did the isthmus cryoablation and modified right-sided
maze groups. These data show important trends, which
should stimulate earlier referral, before the onset of atrial
fibrillation at a time when the less invasive and more expe-
dient modified right-sided maze procedure can be per-
formed. Other beneficial effects of early operation include
prevention of progressive myocardial dysfunction caused by
atrial arrhythmias, cessation of potentially toxic antiarrhyth-
mic agents, and improved functional class that is associated
with Fontan conversion and arrhythmia surgery.
Exercise Tolerance 
It is interesting to speculate on the predominant causative fac-
tor for improved exercise tolerance: the anatomic repair,
arrhythmia ablation, antiarrhythmic agent cessation, or self-
directed physical conditioning through exercise. All of these
therapeutic modalities have been associated with increased
functional class and/or improved ventricular function.35,36
The principal indication for operation in our cohort of 12
patients who underwent preoperative and postoperative exer-
cise testing was atrial reentry tachycardia in 7 patients, path-
way obstructions in 4, and circular venous circulation in 1.
Because of the small number of cases, and because multiple
therapeutic interventions were performed simultaneously, it
would appear that the relative hierarchical therapeutic impor-
tance of any single intervention would require a carefully con-
trolled study with large numbers of subjects. 
Fontan conversion with arrhythmia surgery is a safe and
efficacious operation. Patient selection and adherence to stan-
dard reoperative techniques should optimize outcome.
Debilitating arrhythmias are cured, and patients have an
improvement in functional class and perform significantly
better during exercise testing. We recommend that patients
with atriopulmonary Fontan connections be closely moni-
tored for the development of obstructive pathways, valvular
dysfunction, and atrial arrhythmias. Fontan conversion should
be seriously considered under these circumstances, even if the
only indication is debilitating atrial arrhythmias. Surgical
intervention before the development of atrial fibrillation
results in less surgical morbidity. Cardiac transplantation may
be required in the short- or long-term in some of these
patients; however, in our experience, the long-term outcome
of patients with identifiable causes of ventricular dysfunction
treated with Fontan conversion is superior to the outcome of
those referred for cardiac transplantation. 
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Discussion 
Dr Scott M. Bradley (Charleston, SC). Since its introduction
in the mid-1990s, Fontan conversion has resulted in significant
hemodynamic improvement in patients with failing Fontan opera-
tions. Unfortunately, it has also become apparent that isolated
Fontan conversion provides inconsistent control of atrial arrhyth-
mias, despite the fact that it may include removal of a portion of
the atrium and elimination of high pressure within the atrium. Dr
Mavroudis and his group have pioneered the concept of adding
antiarrhythmia surgery to Fontan conversion. Their approach has
included both the placement of specific intra-atrial lesions and the
placement of a permanent transmural pacemaking lead for anti-
tachycardia and bradycardia pacing therapies. This report docu-
ments their evolution to a standardized right-sided approach for
atrial reentry tachycardia and a combined right- and left-sided
approach (maze III) for atrial fibrillation. At a mean follow-up of
21⁄2 years, there has been excellent control of atrial arrhythmias,
which is a clear improvement over Fontan conversion alone. 
The overall surgical results in these 40 patients were outstanding.
This is particularly notable because each of these is a lengthy, repeat
operation in a patient with palliated cardiovascular physiology. 
I have several questions. The first concerns your current use of
mapping. Since you have evolved to a fairly standardized operative
approach, do you still find preoperative and, in particular, intraop-
erative mapping to be of use? If so, how does it currently modify
your operative approach? 
Second, 2 of your patients, who had no preoperative arrhyth-
mias, underwent prophylactic arrhythmia surgery at the time of
Fontan conversion. Do you recommend this prophylactic approach
in all such patients undergoing Fontan conversion? If so, which
arrhythmia operation should be done: right-sided alone or com-
bined right- and left-sided? 
Finally, could you expand on who should not have this opera-
tion? Obviously the choice between heart transplantation and
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Fontan conversion can be a difficult one in specific patients.
Ventricular function provides some guidance in making this deci-
sion. Have you developed any other more specific criteria for
deciding who should not undergo a Fontan conversion? 
In the future we look forward to further reports on your patients
and, in particular, their rhythm status with longer-term follow up.
I congratulate you for your innovative approach and for leading
our field in this endeavor.
Dr Mavroudis. We performed conscientious mapping in all
patients, certainly early on; otherwise we never would have come
to the conclusion that the isthmus block was not effective therapy
and that we had to proceed to a more standardized operation.
Therefore, this has helped us. However, at present we do not need
to do intraoperative electrophysiologic mapping because the oper-
ation has been standardized to 2 types: right-sided maze for atrial
reentry tachycardia and maze–Cox III for atrial fibrillation. We
continue to do it so that we might find some other parts of the reen-
trant circuits that might be helpful to us in the future. For those
who are attempting to do this operation, I think a preoperative elec-
trophysiologic study in the catheterization laboratory is sufficient;
it would not have to be done in the operating room. 
We performed prophylactic ablations in 2 patients for a number
of reasons. Extracardiac connections limit intracardiac access for
subsequent arrhythmia therapy whether it is for catheter ablation or
pacemaker implantation. The added time to perform prophylactic
ablation did not present a major impediment, and we thought it
prudent to anticipate the possibility of future arrhythmias with a
possible solution. I think it was just an educated guess at that point
whether they would need it or not. 
That this type of arrhythmia surgery should be done in all
patients undergoing a primary Fontan operation is an issue for fur-
ther study. Edward Bove’s group has performed prophylactic inci-
sions, not cryoablations, and found that no protective effect as to
new arrhythmias was realized. We are embarking on a study now
to try to answer that question, although a large number of patients
will be needed. 
The question of whether to perform cardiac transplantation or
Fontan revision is an interesting one. Our present policy and pos-
ture, such as it is, is that if we find a substrate that can be repaired,
such as a valve lesion, an obstructive lesion, or cardiac dysfunction
based on arrhythmias, then we would prefer to attempt a Fontan
revision. If none of these causative substrates can be found and if
function is poor, then we would recommend cardiac transplanta-
tion, as we have in 5 patients who are not included in this cohort
of patients. 
Dr Francis Fontan (Bordeaux, France). Dr Mavroudis, I
would like to congratulate you for these superb results and your
pioneering work in this difficult field of cardiac surgery. I would
like to ask you 3 questions. 
No patient in your series had protein-losing enteropathy. Is that
because, in your opinion, protein-losing enteropathy is a con-
traindication to conversion? 
You already were asked a question about the 2 patients who had
no preoperative atrial arrhythmias. What was the reason for conver-
sion, first, in these 2 patients, and why did you perform arrhythmia
surgery since, due to the postoperative unloading of the remnants of
the right atrium, late atrial arrhythmias are very unlikely? 
Finally, I would like to ask your opinion regarding the long and
still debated question of fenestration, which personally I do not favor. 
Dr Mavroudis. It is a great honor for me to answer a question
from you, Professor Fontan, who started this whole pathway, and I
thank you for your questions. 
We did not really exclude patients with protein-losing enteropa-
thy. They simply were the types of patients who were not referred
because of the severity of their disease. I believe that we deferred
to operate on 2 such patients because of poor ventricular function.
We did, however, operate on our 41st patient recently, last month,
who had had protein-losing enteropathy. I did not include that
patient in this series mainly because we really do not know his
results and will not know them for another 4 or 5 months. He is
doing well, but the outcome of the operation on the state of his pro-
tein-losing enteropathy is uncertain. Categorically, we would not
exclude a patient with protein-losing enteropathy with the experi-
ence we have had so far, but I think we would have to ascribe a
higher mortality for that particular patient. 
A number of groups have tried unloading the right atrium in
light of repairing pathway obstructions, thinking that would be
enough to cure the atrial arrhythmia. None of these attempts has
been successful so far as I can see. We believe that any time a
Fontan conversion is attempted, it should be accompanied by an
appropriate arrhythmia operation, as noted in this presentation. 
Fenestration, of course, continues to be a controversy. In those
patients with protein-losing enteropathy, fenestration will certainly
increase cardiac output. Jack Rychik and Tom Spray from
Philadelphia have promoted the idea that decreased cardiac output
is a causative factor for protein-losing enteropathy. Under these
circumstances, increasing cardiac output by fenestration may help
to ameliorate the problem. We use fenestration selectively, but not
in this particular group of patients unless they have protein-losing
enteropathy.
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